Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Assets Average (2016 - 2025)

Historic Assets Average for Lexaria Bioscience (LEXX) over the last 15 years, with Q4 2025 value amounting to $5.1 million.

  • Lexaria Bioscience's Assets Average fell 4520.33% to $5.1 million in Q4 2025 from the same period last year, while for Nov 2025 it was $5.1 million, marking a year-over-year decrease of 4520.33%. This contributed to the annual value of $6.5 million for FY2025, which is 912.95% up from last year.
  • As of Q4 2025, Lexaria Bioscience's Assets Average stood at $5.1 million, which was down 4520.33% from $5.5 million recorded in Q3 2025.
  • Lexaria Bioscience's Assets Average's 5-year high stood at $12.5 million during Q4 2021, with a 5-year trough of $3.2 million in Q4 2023.
  • For the 5-year period, Lexaria Bioscience's Assets Average averaged around $7.7 million, with its median value being $7.6 million (2024).
  • As far as peak fluctuations go, Lexaria Bioscience's Assets Average skyrocketed by 39997.44% in 2021, and later crashed by 6267.44% in 2023.
  • Over the past 5 years, Lexaria Bioscience's Assets Average (Quarter) stood at $12.5 million in 2021, then plummeted by 45.16% to $6.9 million in 2022, then tumbled by 53.06% to $3.2 million in 2023, then soared by 189.85% to $9.3 million in 2024, then plummeted by 45.2% to $5.1 million in 2025.
  • Its Assets Average was $5.1 million in Q4 2025, compared to $5.5 million in Q3 2025 and $7.7 million in Q2 2025.